14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
KIDS vs OFIX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 19, 2026, Orthofix Medical Inc. (OFIX) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas OFIX carries 47.8/100 (HOLD) at $6.34 (N/M Forward P/E, -2.1% operating margin).
Growth vs. Quality Trade-Off: OFIX earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. KIDS 45.1/100 HOLD) and 1.05β · 85% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile OFIX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KIDS vs OFIX. Trailing 12-month operating profitability (KIDS -8.2% vs OFIX -2.1%) and valuation multiples (KIDS N/M vs OFIX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $269.4M market capitalization and -2.1% operating margin.
OpEx & R&D Reinvestment72.9% of Rev ($609M)
90D Engineering Disclosures0 Published
Investor FAQ KIDS vs OFIX Key Questions & Quantitative Answers
As of Nov 19, 2026, Orthofix Medical Inc. (OFIX) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). KIDS carries a Unified Composite Score of 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin), whereas OFIX carries 47.8/100 (HOLD) at $6.34 (N/M Forward P/E, -2.1% operating margin). Growth vs. Quality Trade-Off: OFIX earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. KIDS 45.1/100 HOLD) and 1.05β · 85% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2); meanwhile OFIX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KIDS leads the Growth & Scale pillar: KIDS posts +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin), compared with OFIX at +1.1% YoY revenue growth and +0.0% YoY earnings growth on $835M TTM revenue (70.8% gross margin, -2.1% operating margin). On trailing 12-month operating scale, KIDS generates $264M in USD-normalized revenue versus $835M for OFIX. In operating R&D and SG&A reinvestment, KIDS deploys 82.0% of Rev ($217M) (0 90-day corporate R&D disclosures) versus 72.9% of Rev ($609M) (0 disclosures) for OFIX.
OFIX screens cheaper on headline valuation multiples. KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin), whereas OFIX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (4.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KIDS (-9.8% ROE) versus OFIX (-10.3% ROE) capital efficiency.
In options market volatility and institutional positioning, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk). By comparison, OFIX carries 40.1% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.05β · 85% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.